Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study. - sprookjes - yvandenbroek - TriplyDB

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

http://www.wikidata.org/entity/Q34358022

about

Role of central dopamine in pain and analgesia The endocannabinoid system in normal and pathological brain ageing Cannabinoids in health and disease Adverse effects of medical cannabinoids: a systematic review [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor Herbal medicines for Parkinson's disease: a systematic review of randomized controlled trials Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics Mechanisms for alternative treatments in Parkinson's disease: acupuncture, tai chi, and other treatments.A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease.Self-reported efficacy of cannabis and other complementary medicine modalities by Parkinson's disease patients in colorado.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels The endocannabinoid system as a target for the treatment of neurodegenerative disease.Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.Medical marijuana in neurology.Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.Cannabinoid-based medicines for neurological disorders--clinical evidence.Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.Cannabidiol: a promising drug for neurodegenerative disorders?The therapeutic potential of cannabinoids for movement disorders.Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia.New insights on endocannabinoid transmission in psychomotor disorders.Novel pharmacological strategies for motor complications in Parkinson's disease.Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.Implication of cannabinoids in neurological diseases.Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: a systematic review.Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure.Cannabis and endocannabinoid modulators: Therapeutic promises and challenges.On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?Treatment of levodopa-induced motor complications.The endocannabinoid system in neuropathological states.Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders.Prospects for cannabinoid therapies in basal ganglia disorders.Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?Endocannabinoid modulation of dopaminergic motor circuits.

P2860

Q22241489-DBFE29F1-1D8B-4142-ACEB-AA81715B47F9 Q22242668-BE5BB9EF-DAEA-49FE-ACBB-AFEDA2D035C6 Q24633884-57138551-2CA9-421E-9413-D355496B9849 Q24644380-A580BB40-FD76-42B9-8768-00C5337959CE Q24680848-D4DAEECD-613B-4CA5-A8A7-EF188AA92178 Q27012917-7A0D8E31-4D8E-461C-88B9-CAB44BCC3590 Q27336419-F083257D-8683-44EB-8ECC-EFFEC0FE5EB7 Q30361677-7CC2F085-616B-4CFC-9051-A71E58D491B6 Q30365907-3C234A71-60E9-4787-B3F0-FD5B5F09B62B Q30373216-7FF7A6CB-BFC9-41E0-8174-F87238DE1C6C Q33751118-4687D335-B926-454D-8707-7AE2C68C5EFE Q33996977-30CD0D56-117E-4F77-852C-46892B291924 Q34098196-C2232523-84C9-423C-ADE9-1216B9036D21 Q34417710-FF3EAFA6-98E3-4F67-8BE3-A8D9A7737D24 Q34449698-914A9D94-4858-48F2-851A-1BBBA6DB859B Q34680801-C0D450C3-8514-42EB-8E4B-A8231A3C3B1C Q34704890-6E1F160F-C924-42EB-B663-1A84839AAAAE Q34849183-F9441B5A-7C8C-48A3-B467-4DB3E816C591 Q34948216-6B27AFC5-5C09-476D-B54B-547004618289 Q35171113-CB796587-B499-4FB7-8077-061EB6966214 Q35499568-298DB8A7-0330-4870-8E35-6F6A4E36A01D Q35781874-5604FD61-0A3C-47AE-A220-5E53D0FD7CE3 Q36074595-C31168D4-C27C-4770-882B-45034F8BDDFF Q36120761-5A1F92E3-93E0-45AF-8003-442A5C9D3C69 Q36155898-B0392284-E4ED-4CEE-9AFE-D0B78169EBD6 Q36248857-0F9C24A8-82B5-4AFC-B70B-3006B8F455AD Q36478301-23D8E506-490F-4D0F-830F-FF421EA6A10F Q36531771-0137AE7D-9568-4790-86F8-BE9031081CE8 Q36549794-DFA27186-D1C4-4362-9973-671CE90041CF Q36892931-FCB8E497-D834-49B2-8C11-3C8F7E449C9B Q36916114-85BC5504-364D-45DB-ACF8-49B18D54565F Q37077360-BCE8FD3B-0074-405D-950A-98CF16A52084 Q37264482-7B8C645E-A6CD-4BBF-88C8-C1530C894E9B Q37444824-C3F23A6E-4C84-4E64-80F9-EB3B18497862 Q37512670-E02C905D-2A4A-4508-A16E-65625E5D59EB Q37716740-53CD3816-2ADB-46EC-9B66-953D4A22AFD2 Q37734568-0AFF3093-1653-4346-830B-0EC8025DE53D Q37872326-C7FF0BC2-2AFD-4AB3-A5C7-13BA5F6CF190 Q38012845-CD017747-F42A-47AD-8379-50591E416494 Q38018946-8FE336F2-5FD9-4A61-AF2B-2F836EFEBE29

P2860

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

http://www.wikidata.org/entity/Q34358022

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

@ast

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

@en

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

@nl

type

label

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

@ast

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

@en

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

@nl

prefLabel

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

@ast

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

@en

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

@nl

P1433

Q34358022-06240820-FB12-4C21-A5B4-917E1F548A04

P1476

Q34358022-97F0DA23-7F74-400A-A274-CA80B69A80A4

P2093

Q34358022-0EB20E42-68F8-4FA4-8980-69FA8CC221B7

Q34358022-10FE1CE9-ED4A-4636-88C4-112787E28D7A

Q34358022-1A3CC4F6-41E0-4E7D-AF96-33E221D85D5E

Q34358022-58EFFF81-B888-4659-B371-C71DD5DBE938

Q34358022-6F66E4BF-FA47-491B-8F71-3007600CF1D3

Q34358022-73550B27-2F36-483A-8372-FE9CB230EB01

Q34358022-882D13A4-FC5B-4636-8F57-A3919410134C

Q34358022-A2CD19FC-B652-4049-A937-EDD9D5EDD4F2

Q34358022-B854C71D-197D-449A-888C-9CC66F33FB24

Q34358022-C643B691-6DDA-436A-A946-E9113A059A1D

P304

Q34358022-4739115A-44C3-458F-ACDE-2CDF1E3B0AD3

P31

Q34358022-AD45A782-7C96-49EC-9EEB-1031D0EB9697

P356

Q34358022-F9476971-1FF5-46A5-ABC3-7DAF0365A962

P407

Q34358022-2AE5F5B0-5FBE-4201-8519-39D90E60ADAF

P433

Q34358022-23A4E829-39E4-4C6D-A1CF-69543AAAF487

P478

Q34358022-A8314817-1977-45E3-8989-23CF7B853979

P577

Q34358022-A7B49FC1-7762-4309-89C0-F61CCB466873

P698

Q34358022-48282289-A6C1-42B4-ACE5-D198D45577E0

P921

Q34358022-B3F2855A-1985-4F91-829E-1DB748893D5D

Q34358022-F115B282-4C27-4792-90CA-F99504607A24

P356

01.WNL.0000140288.48796.8E

P1433

P1476

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

@en

P2093

Bain PG

http://www.w3.org/2001/XMLSchema#string

Carroll CB

http://www.w3.org/2001/XMLSchema#string

Fox P

http://www.w3.org/2001/XMLSchema#string

Hobart J

http://www.w3.org/2001/XMLSchema#string

Joint C

http://www.w3.org/2001/XMLSchema#string

Liu X

http://www.w3.org/2001/XMLSchema#string

Parkin SG

http://www.w3.org/2001/XMLSchema#string

Teare L

http://www.w3.org/2001/XMLSchema#string

Wright D

http://www.w3.org/2001/XMLSchema#string

Wroath C

http://www.w3.org/2001/XMLSchema#string

P304

1245-1250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/01.WNL.0000140288.48796.8E

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15477546

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease